Nocentini Alessio, Vullo Daniela, Bartolucci Gianluca, Supuran Claudiu T
Università degli Studi di Firenze, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino (Florence), Italy.
Università degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence), Italy.
Bioorg Med Chem. 2016 Aug 15;24(16):3612-7. doi: 10.1016/j.bmc.2016.05.072. Epub 2016 May 30.
A series of N(1)-substituted aromatic sulfonamides was obtained by applying a selective sulfonamide nitration synthetic strategy leading to Ar-SO2NHNO2 derivatives which were investigated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. Two human (h) hCA isoforms, the cytosolic hCA II and the transmembrane hCA IX, in addition to the fungal enzyme from Malassezia globosa, MgCA, were included in the study. Most of the new compounds reported selectively inhibited hCA IX over hCA II and at the same time showed effective MgCA inhibitory properties, with KIs ranging between 0.22 and 8.09μM. The N-nitro sulfonamides are a new chemotype with CA inhibitory effects. As hCA IX was recently validated as antitumor/antimetastatic drug target, its selective inhibition could be exploited for interesting biomedical applications. Moreover, due to the effective MgCAs inhibitory properties of the N-nitro sulfonamides, of considerable interest in the cosmetics field as potential anti-dandruff agents, the N-nitro sulfonamides may be considered as interesting leads for the design of more efficient compounds targeting fungal enzymes.
通过应用选择性磺酰胺硝化合成策略,获得了一系列N(1)-取代的芳基磺酰胺,该策略可生成Ar-SO2NHNO2衍生物,并将其作为碳酸酐酶(CA,EC 4.2.1.1)抑制剂进行了研究。该研究纳入了两种人类(h)CA同工型,即胞质hCA II和跨膜hCA IX,以及来自球形马拉色菌的真菌酶MgCA。所报道的大多数新化合物对hCA IX的选择性高于hCA II,同时还表现出有效的MgCA抑制特性,其抑制常数(KI)在0.22至8.09μM之间。N-硝基磺酰胺是一种具有CA抑制作用的新型化学类型。由于hCA IX最近被确认为抗肿瘤/抗转移药物靶点,其选择性抑制可用于有趣的生物医学应用。此外,由于N-硝基磺酰胺对MgCAs具有有效的抑制特性,在化妆品领域作为潜在的去屑剂具有相当大的吸引力,因此N-硝基磺酰胺可被视为设计针对真菌酶的更高效化合物的有趣先导化合物。